JPMorgan Chase & Co’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.42M Sell
122,370
-80,520
-40% -$932K ﹤0.01% 3538
2025
Q1
$1.77M Sell
202,890
-94,012
-32% -$821K ﹤0.01% 3335
2024
Q4
$4.26M Sell
296,902
-58,586
-16% -$841K ﹤0.01% 2861
2024
Q3
$8.03M Buy
355,488
+277,355
+355% +$6.26M ﹤0.01% 2310
2024
Q2
$1.52M Sell
78,133
-1,301
-2% -$25.3K ﹤0.01% 3270
2024
Q1
$2.98M Sell
79,434
-1,395,852
-95% -$52.4M ﹤0.01% 2885
2023
Q4
$82.6M Buy
1,475,286
+243,124
+20% +$13.6M 0.01% 902
2023
Q3
$50.8M Sell
1,232,162
-111,170
-8% -$4.59M 0.01% 1011
2023
Q2
$75M Buy
1,343,332
+70,597
+6% +$3.94M 0.01% 889
2023
Q1
$71M Buy
1,272,735
+10,835
+0.9% +$604K 0.01% 863
2022
Q4
$46M Buy
1,261,900
+55,496
+5% +$2.02M 0.01% 1028
2022
Q3
$34.4M Buy
1,206,404
+196,482
+19% +$5.6M ﹤0.01% 1113
2022
Q2
$45.7M Buy
1,009,922
+926,161
+1,106% +$41.9M 0.01% 1004
2022
Q1
$6.37M Sell
83,761
-63,593
-43% -$4.84M ﹤0.01% 2378
2021
Q4
$22M Sell
147,354
-80,199
-35% -$11.9M ﹤0.01% 1525
2021
Q3
$33.1M Buy
227,553
+181,175
+391% +$26.4M ﹤0.01% 1259
2021
Q2
$9.08M Sell
46,378
-55,867
-55% -$10.9M ﹤0.01% 2209
2021
Q1
$18.5M Sell
102,245
-46,057
-31% -$8.34M ﹤0.01% 1659
2020
Q4
$21M Sell
148,302
-35,942
-20% -$5.09M ﹤0.01% 1407
2020
Q3
$23M Sell
184,244
-91,456
-33% -$11.4M ﹤0.01% 1252
2020
Q2
$24.6M Buy
275,700
+31,443
+13% +$2.81M ﹤0.01% 1131
2020
Q1
$15.2M Sell
244,257
-25,049
-9% -$1.56M ﹤0.01% 1300
2019
Q4
$20.5M Buy
269,306
+54,155
+25% +$4.13M ﹤0.01% 1348
2019
Q3
$10.8M Buy
+215,151
New +$10.8M ﹤0.01% 1753